From: Prognostic significance of COVID-19 MSCT chest findings on short-term disease progression
Centrality | Group A | Group B | Group C | Group D | Test value* | p-value | ||||
---|---|---|---|---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | No. | % | |||
Peripheral | 75 | 100.0% | 121 | 96.8% | 52 | 61.2% | 1 | 6.7% | 122.866 | 0.001 |
Central | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | ||
Confluent | 0 | 0.0% | 4 | 3.2% | 33 | 38.8% | 14 | 93.3% |